Gamma interferon (IFN gamma) is an important lymphokine that Plays a pivotal role in the regulation of essential immune functions in host defense against cancer. Among these are: (1) modulation of expression of products of the major histocompatibility complex on the cell membrane, particularly the upregulation of expression of Ia antigens or macrophages; (2) priming/activation of macrophages for tumor cell killing; (3) enhancement of cytoxicity of lymphocytes, including that of antigen stimulated T lymphocytes and that of natural killer cells against tumor cells: (4) maturation of B cells for immunoglobulin secretion which, depending on the stage of clonal expansion of the cells, is manifested as either enhancement or suppression of antibody production. We propose to further examine the structure/function basis for the biological effects of IFN gamma using the synthetic peptide approach with monoclonal and polyclonal antibodies to IFN gamma and IFN gamma synthetic peptides. It is planed that the objective be achieved through the following approach: (1) generate monoclonal antibodies to mouse (and human) IFN gamma and determine their ability to block function and/or binding of IFN gamma to membrane receptors; (2) map epitope specificity of monoclonal antibodies using synthetic peptides that correspond to regions of the IFN gamma molecule that are located on the surface; initial mapping will involve longer peptides, followed by use of shorter peptides for possibly more precise mapping; (3) use synthetic peptides to produce monoclonal and polyclonal antibodies and determine their effect on function and receptor binding by IFN gamma; (4) determine the steric relationships of epitopes by competitive binding between monoclonal antibodies (and their Fab fragments) of defined epitope specificities with the IFN gamma molecule; (5) perform competitive receptor binding and functional experiments between synthetic peptides and IFN gamma, and determine the ability of appropriate peptides to bind to IFN gamma receptor; particular emphasis will placed on the use of longer peptides; (6) modify peptides that are important in epitope mapping and receptor competition by systematic removal and/or substitution of amino acids in order to more precisely identify sequences or regions of IFN gamma that are involved in function; (7) synthesize hybrid molecules to help identify discontinuous regions of the IFN gamma molecule that may act cooperatively to form structures that are critical for IFN gamma function. The proposed studies are important because they will provide information on the structural basis for the action of IFN gamma in regulation of immune functions and neoplasia.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA038587-07
Application #
3176671
Study Section
Experimental Immunology Study Section (EI)
Project Start
1984-12-01
Project End
1993-05-31
Budget Start
1991-06-01
Budget End
1992-05-31
Support Year
7
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Florida
Department
Type
Schools of Earth Sciences/Natur
DUNS #
073130411
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Ahmed, C M Iqbal; Burkhart, Marjorie A; Mujtaba, Mustafa G et al. (2003) The role of IFNgamma nuclear localization sequence in intracellular function. J Cell Sci 116:3089-98
Subramaniam, Prem S; Johnson, Howard M (2002) Lipid microdomains are required sites for the selective endocytosis and nuclear translocation of IFN-gamma, its receptor chain IFN-gamma receptor-1, and the phosphorylation and nuclear translocation of STAT1alpha. J Immunol 169:1959-69
Larkin 3rd, J; Subramaniam, P S; Torres, B A et al. (2001) Differential properties of two putative nuclear localization sequences found in the carboxyl-terminus of human ifn-gamma. J Interferon Cytokine Res 21:341-8
Subramaniam, P S; Torres, B A; Johnson, H M (2001) So many ligands, so few transcription factors: a new paradigm for signaling through the STAT transcription factors. Cytokine 15:175-87
Torres, B A; Kominsky, S; Perrin, G Q et al. (2001) Superantigens: the good, the bad, and the ugly. Exp Biol Med (Maywood) 226:164-76
Subramaniam, P S; Green, M M; Larkin 3rd, J et al. (2001) Nuclear translocation of IFN-gamma is an intrinsic requirement for its biologic activity and can be driven by a heterologous nuclear localization sequence. J Interferon Cytokine Res 21:951-9
Larkin 3rd, J; Johnson, H M; Subramaniam, P S (2000) Differential nuclear localization of the IFNGR-1 and IFNGR-2 subunits of the IFN-gamma receptor complex following activation by IFN-gamma. J Interferon Cytokine Res 20:565-76
Kominsky, S L; Hobeika, A C; Lake, F A et al. (2000) Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells. Cancer Res 60:3904-8
Kominsky, S L; Subramaniam, P S; Johnson, H M et al. (2000) Inhibitory effects of IFN-gamma and acyclovir on the glioblastoma cell cycle. J Interferon Cytokine Res 20:463-9
Subramaniam, P S; Larkin 3rd, J; Mujtaba, M G et al. (2000) The COOH-terminal nuclear localization sequence of interferon gamma regulates STAT1 alpha nuclear translocation at an intracellular site. J Cell Sci 113 ( Pt 15):2771-81

Showing the most recent 10 out of 33 publications